DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Regeneron Pharmaceuticals is a leading biotech focused on gene editing. While the S&P 500 has dipped lower in November, ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Learn more about whether Ultragenyx Pharmaceutical Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

A lot can change in five years. Take Vertex Pharmaceuticals (NASDAQ: VRTX), for example. In late 2020, the big biotech ...

Tariff pressures, a changing regulatory environment, and risk-averse investors have left many Cambridge biotechnology ...

Jyong Biotech advances plant-derived carotenoid drugs with MCS-2 for BPH and early programs like MCS-8 showing signals as ...

Mumbai, Nov 26: Maharashtra will soon set up a world-class Life Sciences Innovation and Incubation Centre to accelerate ...

Visit to Klang manufacturing facility held in conjunction with 14th SMIIC Technical Committee Week 2025 in Kuala Lumpur November 2, 2025-- Kuala Lumpur, 16 October 2025 — Duopharma Biotech Berhad ...

The state government preparing to establish a state-of-the-art Life Sciences Innovation and Incubation Centre in Maharashtra ...